TH-1904

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameTH-1904
Drug Alias NameTH-1904
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDNA intercalatorsTopoisomerase (DNA) II alpha inhibitors
TargetsDNATopoisomerase (DNA) II alpha
Therapy Area/IndicationsOvarian Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesKatana Biopharma Inc
China Registration ClassN/A

Develop Information

Active CompaniesKatana Biopharma Inc
Inactive CompaniesN/A
Active IndicationsOvarian Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A